PSA test results: how they are read
There is no single PSA level that separates normal from abnormal, and no age chart that major groups endorse. This page explains how doctors read a result and what usually happens next. It cannot interpret your number: your doctor decides, with your age, history and other tests. (NCI, 2025) (ACS, 2023)
How the number is read
PSA is measured in nanograms per milliliter (ng/mL). The chance of prostate cancer rises as PSA rises, but there is no cutoff that tells for sure. (ACS, 2023) (NCI, 2025)
| PSA (ng/mL) | What the American Cancer Society says |
|---|---|
| Under 4 | Most men without prostate cancer are in this range, though cancer is still possible; some doctors look further from 2.5 or 3 (ACS, 2023) |
| 4 to 10 ("borderline") | About a 1 in 4 chance of prostate cancer (ACS, 2023) |
| Over 10 | The chance of prostate cancer is over 50% (ACS, 2023) |
Why there is no PSA-by-age chart here
PSA normally rises slowly with age. Some doctors have suggested comparing results with men of the same age, and the National Cancer Institute notes that some apply a higher cutoff (such as 5) for older men and a lower one (such as 2.5) for younger men. But the American Cancer Society says age-specific ranges are not well proven, and most doctors and professional organizations do not recommend them. So we do not publish a chart. (NCI, 2025) (ACS, 2023)
Other PSA measures your doctor may use
- Percent-free PSA: may help decide on a biopsy when PSA is between 4 and 10; a lower percentage means a higher chance of cancer. (ACS, 2023)
- PSA density: PSA divided by prostate size, sometimes used for men with large prostates; higher density means a greater likelihood of cancer. (ACS, 2023)
- PSA velocity: how fast PSA rises over time; studies have not shown it helps more than the PSA level itself, so most doctors do not use it for screening. (ACS, 2023)
Older age, an enlarged prostate (BPH), prostatitis and recent ejaculation can raise PSA; finasteride and dutasteride lower it, so a lower cutoff is used for men taking them. Tell your doctor about these before the test. (ACS, 2023) (NCI, 2025)
What usually happens after a high result
- A repeat PSA test, often in 6 to 8 weeks, to confirm the result. (NCI, 2025)
- If it is still high: watching with repeat PSA tests and rectal exams, or further tests such as an MRI. (NCI, 2025)
- A biopsy if your doctor recommends one; an MRI-guided biopsy may target areas seen on MRI. (NCI, 2025) What an MRI score means: PI-RADS results.
False positives are common: about 6% to 7% of men have one in any screening round, and only about 25% of men who have a biopsy for a high PSA are found to have cancer. (NCI, 2025) For men 55 to 69, the USPSTF calls PSA screening an individual decision to make with a clinician (grade C), and it recommends against it from 70 (grade D). (USPSTF, 2018) See also what usually happens after an abnormal screening result and shared decision-making.
Questions people ask
What is a normal PSA level for my age?
There is no single normal level. Some doctors have suggested comparing results with men of the same age, but the American Cancer Society says age-specific ranges are not well proven, and most doctors and professional organizations do not recommend using them. Your doctor reads your result with your age and other factors. (ACS, 2023) (NCI, 2025)
Is a PSA of 4 bad?
Many doctors use 4 ng/mL or higher as the point to consider more testing, and some use a lower level such as 2.5 or 3. Between 4 and 10, the American Cancer Society says the chance of prostate cancer is about 1 in 4; above 10 it is over 50%. (ACS, 2023)
Does a high PSA mean I need a biopsy?
Not right away. The National Cancer Institute says a doctor may repeat the PSA test in 6 to 8 weeks to confirm it, and may use an MRI or other tests before deciding on a biopsy. Your doctor decides the next step with you. (NCI, 2025)
What else can raise PSA?
Older age, an enlarged prostate (BPH), prostatitis and recent ejaculation can raise it. Some drugs for BPH, such as finasteride and dutasteride, lower it. (ACS, 2023) (NCI, 2025)